학술논문
Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations
Document Type
Article
Author
Source
In Clinical Lung Cancer July 2016 17(4):245-252
Subject
Language
ISSN
1525-7304